[Home]
[Full version]
Proteins necessary for brain development found to be critical for long-term memory
Sep 05 ,Medicine & Health
A type of protein crucial for the growth of brain cells during development appears to be equally important for the formation of long-term memories, according to researchers at UC Irvine. The findings could lead to a better understanding of, and treatments for, cognitive decline associated with normal aging and diseases such as Alzheimer's.
The findings appear in the early online edition of the Proceedings of the National Academy of Sciences.
"This study presents strong evidence that a molecular process fundamental during development is retained in the adult and recycled in the service of memory formation," said Thomas J. Carew, Donald Bren Professor and chair of UCI's Department of Neurobiology and Behavior. "It is a striking example of how molecular rules employed in building a brain are often reused for different purposes throughout a lifetime."
The researchers have shown that proteins known as growth factors are as essential for the induction of long-term memory as they are for the development of the central nervous system. These growth factors, such as brain derived neurotrophic factor (BDNF), bind onto the brain cell through a specific type of receptor known as TrkB, much the same way a key fits into a lock. As an experimental strategy to determine the importance of BDNF-like growth factors in forming memories, the researchers used a "molecular trick" to keep the proteins from binding with the appropriate TrkB receptors.
For the experiment, the scientists used wild-caught Aplysia, a marine snail frequently studied in learning and memory because of its large brain cells. The Aplysia received a series of five tail shocks, spaced 15 minutes apart. The shocks cause the animals to exhibit heightened withdrawal reflexes days and weeks after the shocks are over.
When the animals are shocked, a brain chemical known as serotonin is released that promotes the formation of a long-term memory associated with the shocks. However, when Carew and his colleagues blocked the interaction between the BDNF-like growth factors and the TrkB receptors, they found that serotonin alone was not enough to retain the long-term memory of the shock. While short-term memory was retained, 24 hours later the snails -- which normally would remember the events of the previous day -- exhibited no memory of the shocks. Carew and colleagues went on to show that, when the actions of the growth factors were prevented, long-term enhancement of the connections between the brain cells in the reflex circuit normally induced by the shock treatment was also blocked.
"We would never have expected that the secretion of these growth factors in response to serotonin would be critical for long-term memory formation in this system," Carew said. "But it is apparent that without them, this process cannot happen."
According to Carew, these findings could open possible avenues for treatments relating to memory loss. "This gives us some strong clues as to what we should be looking into for therapeutic interventions," he said. "If we know that growth factors are important for long-term memory, then we can look at possible remedial roles they might play in diseases such as Alzheimer's and dementia."
Source: University of California, Irvine
Related stories:
Study points to cocktail therapy for Alzheimer's
A dietary cocktail that includes a type of omega-3 fatty acid can improve memory and learning in gerbils, according to the latest study from MIT researchers that points to a possible beverage-based treatment for Alzheimer's and other brain diseases.
Mechanism explains calcium abnormalities in Alzheimer's brain
A new study uncovers a mechanism that directly links mutations that cause early onset Alzheimer's disease (AD) with aberrant calcium signaling. The research, published by Cell Press in the June 26th issue of the journal
Neuron, provides exciting molecular insights into the pathology of AD and may lead to new treatment strategies.
Study of marine snail leads to new insights into long-term memory
UCLA cellular neuroscientists are providing new insights into the mechanisms that underlie long-term memory — research with the potential to treat long-term memory disorders.
Neuroscientists show insulin receptor signaling regulates structure of brain circuits
Impact of the signaling upon synapses and dendrites is shown for the first time in living creatures
A team of neuroscientists at Cold Spring Harbor Laboratory (CSHL) has demonstrated for the first time in living animals that insulin receptors in the brain can initiate signaling that regulates both the structure and function of neural circuits.
Brain stem cells can be awakened, say scientists
Scientists at Schepens Eye Research Institute have identified specific molecules in the brain that are responsible for awakening and putting to sleep brain stem cells, which, when activated, can transform into neurons (nerve cells) and repair damaged brain tissue. Their findings are published online this week in the
Proceedings of the National Academy of Science (PNAS).
Researchers clear up Alzheimer's plaques in mice
Blocking a common immune system response cleared up plaques associated with Alzheimer’s Disease and enabled treated mice to recover some lost memory, Yale University researchers report Friday in the journal
Nature Medicine.
At the synapse: Gene may shed light on neurological disorders
In our brains, where millions of signals move across a network of neurons like runners in a relay race, all the critical baton passes take place at synapses. These small gaps between nerve cell endings have to be just the right size for messages to transmit properly. Synapses that grow too large or too small are associated with motor and cognitive impairment, learning and memory difficulties, and other neurological disorders.
Researchers uncover mechanism of action of antibiotic able to reduce neuronal cell death in brain
Virginia Commonwealth University researchers have discovered how an antibiotic works to modulate the activity of a neurotransmitter that regulates brain functions, which eventually could lead to therapies to treat Alzheimer’s disease, Huntington’s disease, epilepsy, stroke, dementia and malignant gliomas.
[Home]
[Full version]